top of page

The treatment of CECD is through the introduction of exogenous cannabinoids specifically phytocannabinoids such as THC and CBD. Depending on the ailment will depend on the treatment necessary for an efficient recovery. In order to do this you must first figure out what ailment they currently suffer from. Just like any other doctor’s medical treatment would be based on their ailment at hand and they will determine what type of medicine the patient would need and in what dosage.

In the case of an underproduction of anandamide, the phytocannabinoid needed to be introduced would be THC, because the function of THC and anandamide is the same. With arachidonoylglycerol the function of that and the phytocannabinoid, CBG, would need to be introduced because the function of CBG and arachidonoylglycerol are the same. It has been shown that through the introduction of exogenous cannabinoids to increase endogenous cannabinoid production, thus beginning to regulate  your system. The research in the treatment of migraines, irritable bowel syndrome(IBS), and fibromyalgia has been proven by Dr. Ethan Russo in his work Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndrome. 

There are many people in the world that are suffering endlessly for no reason. They are hurting and in serious pain with doctors who are have the best of intentions trying everything in the book to help them without succeeding. Unfortunately because of the way cannabis and cannabinoids are scheduled they are not able to meet the requirements of actually treating people to the fullest and can not explore alternative treatment with something holistic, natural, and safe because you can not die from taking too many cannabinoids. Ultimately we  need to continue to research CECD and how phytocannabinoids can be used to treat “treatment resistant” conditions, to better help the human species as a whole, and to deliver true medicine to mankind.

bottom of page